These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9219043)

  • 1. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency.
    Tome MB; Isaac MT; Harte R; Holland C
    Int Clin Psychopharmacol; 1997 Mar; 12(2):81-9. PubMed ID: 9219043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
    J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R; Thomas P; Dupuis B
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R; Artigas F; Franchini L; Sforzini L; Gasperini M; Smeraldi E; Perez J
    J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB; Cloninger CR; Watson JP; Isaac MT
    J Affect Disord; 1997 Jul; 44(2-3):101-9. PubMed ID: 9241570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V
    J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA
    Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.
    Geretsegger C; Bitterlich W; Stelzig R; Stuppaeck C; Bondy B; Aichhorn W
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):141-6. PubMed ID: 18054209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
    Baldwin DS; Cooper JA; Huusom AK; Hindmarch I
    Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks.
    Tome MB; Isaac MT
    Int Clin Psychopharmacol; 1998 Jul; 13(4):169-74. PubMed ID: 9727727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.
    Safarinejad MR
    J Clin Psychopharmacol; 2008 Feb; 28(1):39-44. PubMed ID: 18204339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
    Kraus RP
    Depression; 1996; 4(2):92-4. PubMed ID: 9160648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
    Bell C; Wilson S; Rich A; Bailey J; Nutt D
    Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze.
    Sela VR; Roncon CM; Zangrossi H; Graeff FG; Audi EA
    Life Sci; 2010 Sep; 87(13-14):445-50. PubMed ID: 20816996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
    Räsänen P; Hakko H; Tiihonen J
    J Clin Psychopharmacol; 1999 Aug; 19(4):297-302. PubMed ID: 10440455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
    Dannon PN; Sasson Y; Hirschmann S; Iancu I; Grunhaus LJ; Zohar J
    Eur Neuropsychopharmacol; 2000 May; 10(3):165-9. PubMed ID: 10793318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.
    Blier P; Bergeron R
    J Clin Psychopharmacol; 1995 Jun; 15(3):217-22. PubMed ID: 7636000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.